| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | type I interferon receptor binding | 2.04e-11 | 17 | 149 | 7 | GO:0005132 | |
| GeneOntologyMolecularFunction | cyclase activity | 2.82e-05 | 24 | 149 | 4 | GO:0009975 | |
| GeneOntologyMolecularFunction | phosphorus-oxygen lyase activity | 3.33e-05 | 25 | 149 | 4 | GO:0016849 | |
| GeneOntologyMolecularFunction | adenylate cyclase activity | 3.06e-04 | 18 | 149 | 3 | GO:0004016 | |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-serine phosphorylation of STAT protein | 9.08e-11 | 21 | 148 | 7 | GO:0033141 | |
| GeneOntologyBiologicalProcess | regulation of peptidyl-serine phosphorylation of STAT protein | 2.65e-10 | 24 | 148 | 7 | GO:0033139 | |
| GeneOntologyBiologicalProcess | natural killer cell activation involved in immune response | 5.58e-10 | 42 | 148 | 8 | GO:0002323 | |
| GeneOntologyBiologicalProcess | serine phosphorylation of STAT protein | 8.86e-10 | 28 | 148 | 7 | GO:0042501 | |
| GeneOntologyBiologicalProcess | interferon-mediated signaling pathway | OAS2 MED1 IFNA4 IFNA8 IFNA10 IFNA16 IFNA17 IFNA21 EPG5 IFNW1 | 8.07e-09 | 112 | 148 | 10 | GO:0140888 |
| GeneOntologyBiologicalProcess | response to exogenous dsRNA | 1.29e-07 | 55 | 148 | 7 | GO:0043330 | |
| GeneOntologyBiologicalProcess | type I interferon-mediated signaling pathway | 1.75e-07 | 85 | 148 | 8 | GO:0060337 | |
| GeneOntologyBiologicalProcess | cellular response to type I interferon | 1.92e-07 | 86 | 148 | 8 | GO:0071357 | |
| GeneOntologyBiologicalProcess | cellular response to virus | 2.74e-07 | 90 | 148 | 8 | GO:0098586 | |
| GeneOntologyBiologicalProcess | response to type I interferon | 3.25e-07 | 92 | 148 | 8 | GO:0034340 | |
| GeneOntologyBiologicalProcess | response to dsRNA | 3.36e-07 | 63 | 148 | 7 | GO:0043331 | |
| GeneOntologyBiologicalProcess | regulation of peptidyl-serine phosphorylation | 6.49e-07 | 137 | 148 | 9 | GO:0033135 | |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-serine phosphorylation | 6.69e-07 | 101 | 148 | 8 | GO:0033138 | |
| GeneOntologyBiologicalProcess | T cell activation involved in immune response | 1.24e-06 | 148 | 148 | 9 | GO:0002286 | |
| GeneOntologyBiologicalProcess | peptidyl-serine phosphorylation | PRKD2 IFNA4 IFNA8 IFNA10 IFNA16 IFNA17 IFNA21 IFNW1 MAP4K1 TNKS BCAR3 DMD | 2.29e-06 | 307 | 148 | 12 | GO:0018105 |
| GeneOntologyBiologicalProcess | response to virus | DUOX2 OAS2 ZNFX1 BCL3 IFNA4 IFNA8 IFNA10 IFNA16 IFNA17 IFNA21 EPG5 LGALS9 IFNW1 MOV10 | 2.41e-06 | 425 | 148 | 14 | GO:0009615 |
| GeneOntologyBiologicalProcess | natural killer cell activation | 3.17e-06 | 124 | 148 | 8 | GO:0030101 | |
| GeneOntologyBiologicalProcess | regulation of receptor signaling pathway via JAK-STAT | 3.37e-06 | 125 | 148 | 8 | GO:0046425 | |
| GeneOntologyBiologicalProcess | peptidyl-serine modification | PRKD2 IFNA4 IFNA8 IFNA10 IFNA16 IFNA17 IFNA21 IFNW1 MAP4K1 TNKS BCAR3 DMD | 3.40e-06 | 319 | 148 | 12 | GO:0018209 |
| GeneOntologyBiologicalProcess | regulation of defense response to virus by host | 5.98e-06 | 63 | 148 | 6 | GO:0050691 | |
| GeneOntologyBiologicalProcess | regulation of receptor signaling pathway via STAT | 9.13e-06 | 143 | 148 | 8 | GO:1904892 | |
| GeneOntologyBiologicalProcess | leukocyte activation involved in immune response | BCL3 ITGAM IFNA4 IFNA8 IFNA10 IFNA16 IFNA17 IFNA21 LGALS9 IFNW1 SUPT6H FES | 1.19e-05 | 361 | 148 | 12 | GO:0002366 |
| GeneOntologyBiologicalProcess | cell activation involved in immune response | BCL3 ITGAM IFNA4 IFNA8 IFNA10 IFNA16 IFNA17 IFNA21 LGALS9 IFNW1 SUPT6H FES | 1.33e-05 | 365 | 148 | 12 | GO:0002263 |
| GeneOntologyBiologicalProcess | lymphocyte activation involved in immune response | BCL3 IFNA4 IFNA8 IFNA10 IFNA16 IFNA17 IFNA21 LGALS9 IFNW1 SUPT6H | 1.39e-05 | 251 | 148 | 10 | GO:0002285 |
| GeneOntologyBiologicalProcess | mononuclear cell differentiation | BCL3 ZMIZ1 MED1 ITGAM IFNA4 IFNA8 IFNA10 IFNA16 IFNA17 IFNA21 LGALS9 FANCA IFNW1 FES SMARCD1 CTNNB1 | 1.51e-05 | 640 | 148 | 16 | GO:1903131 |
| GeneOntologyBiologicalProcess | regulation of AMPA receptor activity | 2.86e-05 | 25 | 148 | 4 | GO:2000311 | |
| GeneOntologyBiologicalProcess | B cell proliferation | 3.17e-05 | 124 | 148 | 7 | GO:0042100 | |
| GeneOntologyBiologicalProcess | defense response to virus | OAS2 ZNFX1 IFNA4 IFNA8 IFNA10 IFNA16 IFNA17 IFNA21 EPG5 IFNW1 MOV10 | 3.76e-05 | 342 | 148 | 11 | GO:0051607 |
| GeneOntologyBiologicalProcess | regulation of defense response to virus | 4.68e-05 | 90 | 148 | 6 | GO:0050688 | |
| GeneOntologyBiologicalProcess | leukocyte differentiation | BCL3 ZMIZ1 MED1 ITGAM IFNA4 IFNA8 IFNA10 IFNA16 IFNA17 IFNA21 LGALS9 FANCA IFNW1 FES SMARCD1 CTNNB1 TMEM64 | 5.30e-05 | 789 | 148 | 17 | GO:0002521 |
| GeneOntologyBiologicalProcess | cell surface receptor signaling pathway via JAK-STAT | 9.37e-05 | 198 | 148 | 8 | GO:0007259 | |
| GeneOntologyBiologicalProcess | neurotransmitter receptor diffusion trapping | 9.82e-05 | 13 | 148 | 3 | GO:0099628 | |
| GeneOntologyBiologicalProcess | postsynaptic neurotransmitter receptor diffusion trapping | 9.82e-05 | 13 | 148 | 3 | GO:0098970 | |
| GeneOntologyBiologicalProcess | B cell differentiation | 1.04e-04 | 201 | 148 | 8 | GO:0030183 | |
| GeneOntologyBiologicalProcess | receptor diffusion trapping | 1.24e-04 | 14 | 148 | 3 | GO:0098953 | |
| GeneOntologyBiologicalProcess | lymphocyte differentiation | BCL3 ZMIZ1 IFNA4 IFNA8 IFNA10 IFNA16 IFNA17 IFNA21 LGALS9 FANCA IFNW1 SMARCD1 CTNNB1 | 1.36e-04 | 537 | 148 | 13 | GO:0030098 |
| GeneOntologyBiologicalProcess | T cell activation | BCL3 ZMIZ1 ITGAM JAML IFNA4 IFNA8 IFNA10 IFNA16 IFNA17 IFNA21 LGALS9 FANCA IFNW1 SMARCD1 CTNNB1 | 1.61e-04 | 701 | 148 | 15 | GO:0042110 |
| GeneOntologyBiologicalProcess | defense response to bacterium | STAB2 OAS2 ZNFX1 BCL3 IFNA4 IFNA8 IFNA10 IFNA16 IFNA17 IFNA21 LGALS9 | 1.69e-04 | 405 | 148 | 11 | GO:0042742 |
| GeneOntologyBiologicalProcess | cell surface receptor signaling pathway via STAT | 1.71e-04 | 216 | 148 | 8 | GO:0097696 | |
| GeneOntologyBiologicalProcess | peptidyl-amino acid modification | PRKD2 DDR1 ZMIZ1 IFNA4 IFNA8 IFNA10 IFNA16 IFNA17 IFNA21 IFNW1 MAP4K1 CSPG4 FES TNKS CTNNB1 BCAR3 DMD TTLL13 | 2.25e-04 | 976 | 148 | 18 | GO:0018193 |
| GeneOntologyBiologicalProcess | regulation of postsynaptic neurotransmitter receptor activity | 2.29e-04 | 17 | 148 | 3 | GO:0098962 | |
| GeneOntologyBiologicalProcess | lactation | 3.88e-04 | 48 | 148 | 4 | GO:0007595 | |
| GeneOntologyBiologicalProcess | humoral immune response | 5.29e-04 | 321 | 148 | 9 | GO:0006959 | |
| GeneOntologyBiologicalProcess | cyclic nucleotide biosynthetic process | 5.77e-04 | 23 | 148 | 3 | GO:0009190 | |
| GeneOntologyBiologicalProcess | lymphocyte proliferation | ITGAM IFNA4 IFNA8 IFNA10 IFNA16 IFNA17 IFNA21 LGALS9 IFNW1 CTNNB1 | 6.14e-04 | 398 | 148 | 10 | GO:0046651 |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter receptor activity | 7.00e-04 | 56 | 148 | 4 | GO:0099601 | |
| GeneOntologyBiologicalProcess | mononuclear cell proliferation | ITGAM IFNA4 IFNA8 IFNA10 IFNA16 IFNA17 IFNA21 LGALS9 IFNW1 CTNNB1 | 7.16e-04 | 406 | 148 | 10 | GO:0032943 |
| GeneOntologyCellularComponent | AMPA glutamate receptor complex | 2.05e-06 | 30 | 148 | 5 | GO:0032281 | |
| GeneOntologyCellularComponent | ionotropic glutamate receptor complex | 1.62e-05 | 45 | 148 | 5 | GO:0008328 | |
| GeneOntologyCellularComponent | neurotransmitter receptor complex | 2.72e-05 | 50 | 148 | 5 | GO:0098878 | |
| Domain | Interferon | 2.81e-11 | 17 | 146 | 7 | PF00143 | |
| Domain | INTERFERON_A_B_D | 2.81e-11 | 17 | 146 | 7 | PS00252 | |
| Domain | Interferon_alpha/beta/delta | 2.81e-11 | 17 | 146 | 7 | IPR000471 | |
| Domain | IFabd | 2.81e-11 | 17 | 146 | 7 | SM00076 | |
| Domain | - | 1.16e-07 | 50 | 146 | 7 | 1.20.1250.10 | |
| Domain | 4_helix_cytokine_core | 1.34e-07 | 51 | 146 | 7 | IPR012351 | |
| Domain | 4_helix_cytokine-like_core | 1.79e-06 | 74 | 146 | 7 | IPR009079 | |
| Domain | Leu-rich_rpt | 2.86e-04 | 271 | 146 | 9 | IPR001611 | |
| Domain | A/G_cyclase_CS | 2.94e-04 | 17 | 146 | 3 | IPR018297 | |
| Domain | ARM-type_fold | 3.40e-04 | 339 | 146 | 10 | IPR016024 | |
| Domain | ZF_ZZ_2 | 3.50e-04 | 18 | 146 | 3 | PS50135 | |
| Domain | ZF_ZZ_1 | 3.50e-04 | 18 | 146 | 3 | PS01357 | |
| Domain | - | 3.50e-04 | 18 | 146 | 3 | 3.30.70.1230 | |
| Domain | ZZ | 3.50e-04 | 18 | 146 | 3 | PF00569 | |
| Domain | Nucleotide_cyclase | 3.50e-04 | 18 | 146 | 3 | IPR029787 | |
| Domain | Guanylate_cyc | 4.14e-04 | 19 | 146 | 3 | PF00211 | |
| Domain | GUANYLATE_CYCLASE_2 | 4.14e-04 | 19 | 146 | 3 | PS50125 | |
| Domain | A/G_cyclase | 4.14e-04 | 19 | 146 | 3 | IPR001054 | |
| Domain | Znf_ZZ | 4.14e-04 | 19 | 146 | 3 | IPR000433 | |
| Domain | GUANYLATE_CYCLASE_1 | 4.14e-04 | 19 | 146 | 3 | PS00452 | |
| Domain | CYCc | 4.14e-04 | 19 | 146 | 3 | SM00044 | |
| Domain | ZnF_ZZ | 4.14e-04 | 19 | 146 | 3 | SM00291 | |
| Domain | Adcy_conserved_dom | 8.92e-04 | 6 | 146 | 2 | IPR009398 | |
| Domain | DUF1053 | 8.92e-04 | 6 | 146 | 2 | PF06327 | |
| Domain | - | 9.65e-04 | 321 | 146 | 9 | 3.80.10.10 | |
| Domain | L_dom-like | 1.12e-03 | 328 | 146 | 9 | IPR032675 | |
| Domain | ARM-like | 1.30e-03 | 270 | 146 | 8 | IPR011989 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_I_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY | 3.96e-10 | 24 | 108 | 7 | M47908 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_TAT_TO_TLR2_4_NFKB_SIGNALING_PATHWAY | 2.03e-09 | 17 | 108 | 6 | M47564 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CGAS_STING_SIGNALING_PATHWAY | 3.03e-09 | 18 | 108 | 6 | M47539 | |
| Pathway | BIOCARTA_IFNA_PATHWAY | 4.40e-09 | 19 | 108 | 6 | MM1571 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF7_SIGNALING_PATHWAY | 4.40e-09 | 19 | 108 | 6 | M47450 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR7_9_IRF7_SIGNALING_PATHWAY | 6.24e-09 | 20 | 108 | 6 | M47617 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_II_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY | 8.69e-09 | 21 | 108 | 6 | M47909 | |
| Pathway | WP_INTERFERONMEDIATED_SIGNALING | 1.08e-08 | 37 | 108 | 7 | M39785 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR7_8_9_IRF5_SIGNALING_PATHWAY | 1.19e-08 | 22 | 108 | 6 | M47897 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RIG_I_NFKB_SIGNALING_PATHWAY | 1.19e-08 | 22 | 108 | 6 | M47616 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_I_IFN_SIGNALING_PATHWAY | 1.60e-08 | 23 | 108 | 6 | M47452 | |
| Pathway | REACTOME_REGULATION_OF_IFNA_IFNB_SIGNALING | 1.60e-08 | 23 | 108 | 6 | MM15634 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RIG_I_IRF7_3_SIGNALING_PATHWAY | 2.11e-08 | 24 | 108 | 6 | M47576 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MDA5_IRF7_3_SIGNALING_PATHWAY | 2.11e-08 | 24 | 108 | 6 | M47782 | |
| Pathway | REACTOME_REGULATION_OF_IFNA_IFNB_SIGNALING | 3.57e-08 | 26 | 108 | 6 | M982 | |
| Pathway | BIOCARTA_CYTOKINE_PATHWAY | 5.77e-08 | 28 | 108 | 6 | MM1378 | |
| Pathway | REACTOME_RSV_HOST_INTERACTIONS | 5.79e-08 | 98 | 108 | 9 | M48247 | |
| Pathway | KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY | 6.51e-08 | 71 | 108 | 8 | M15913 | |
| Pathway | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION | 8.99e-08 | 30 | 108 | 6 | M936 | |
| Pathway | WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY | 1.11e-07 | 31 | 108 | 6 | M39897 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IFN_RIPK1_3_SIGNALING_PATHWAY | 1.11e-07 | 31 | 108 | 6 | M47964 | |
| Pathway | BIOCARTA_INFLAM_PATHWAY | 1.65e-07 | 33 | 108 | 6 | MM1379 | |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 1.99e-07 | 34 | 108 | 6 | MM15631 | |
| Pathway | REACTOME_EVASION_BY_RSV_OF_HOST_INTERFERON_RESPONSES | 2.38e-07 | 35 | 108 | 6 | M48246 | |
| Pathway | KEGG_REGULATION_OF_AUTOPHAGY | 2.38e-07 | 35 | 108 | 6 | M6382 | |
| Pathway | REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY | 3.35e-07 | 120 | 108 | 9 | M48233 | |
| Pathway | WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE | 4.67e-07 | 39 | 108 | 6 | MM15914 | |
| Pathway | BIOCARTA_IL1R_PATHWAY | 6.36e-07 | 41 | 108 | 6 | MM1493 | |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 2.15e-06 | 78 | 108 | 7 | M973 | |
| Pathway | KEGG_AUTOIMMUNE_THYROID_DISEASE | 2.69e-06 | 52 | 108 | 6 | M13103 | |
| Pathway | REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA | 3.02e-06 | 82 | 108 | 7 | M1002 | |
| Pathway | KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY | 3.76e-06 | 55 | 108 | 6 | M11844 | |
| Pathway | PID_CD8_TCR_DOWNSTREAM_PATHWAY | 1.01e-05 | 65 | 108 | 6 | M272 | |
| Pathway | WP_CYTOSOLIC_DNASENSING_PATHWAY | 1.97e-05 | 73 | 108 | 6 | M39837 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 4.80e-05 | 170 | 108 | 8 | M941 | |
| Pathway | REACTOME_SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES | 5.09e-05 | 126 | 108 | 7 | M45009 | |
| Pathway | WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS | 5.35e-05 | 127 | 108 | 7 | M42533 | |
| Pathway | WP_IL2_SIGNALING_PATHWAY | 5.37e-05 | 87 | 108 | 6 | MM15915 | |
| Pathway | KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION | 5.73e-05 | 88 | 108 | 6 | M16004 | |
| Pathway | KEGG_DILATED_CARDIOMYOPATHY | 6.50e-05 | 90 | 108 | 6 | M835 | |
| Pathway | WP_MEASLES_VIRUS_INFECTION | 8.26e-05 | 136 | 108 | 7 | M42547 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 9.06e-05 | 138 | 108 | 7 | MM15635 | |
| Pathway | KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY | 1.30e-04 | 102 | 108 | 6 | M3261 | |
| Pathway | WP_TOLLLIKE_RECEPTOR_SIGNALING | 1.38e-04 | 103 | 108 | 6 | M39434 | |
| Pathway | WP_HEPATITIS_B_INFECTION | 1.59e-04 | 151 | 108 | 7 | M39801 | |
| Pathway | KEGG_JAK_STAT_SIGNALING_PATHWAY | 1.87e-04 | 155 | 108 | 7 | M17411 | |
| Pathway | KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC | 2.55e-04 | 74 | 108 | 5 | M16376 | |
| Pathway | WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY | 2.55e-04 | 74 | 108 | 5 | M39462 | |
| Pathway | REACTOME_SARS_COV_2_INFECTION | 4.80e-04 | 299 | 108 | 9 | M41727 | |
| Pathway | KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY | 6.42e-04 | 137 | 108 | 6 | M5669 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 8.90e-04 | 326 | 108 | 9 | MM15917 | |
| Pathway | REACTOME_SARS_COV_2_HOST_INTERACTIONS | 9.74e-04 | 204 | 108 | 7 | M45011 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 1.18e-03 | 273 | 108 | 8 | M983 | |
| Pubmed | Characterization of the murine alpha interferon gene family. | 8.06e-14 | 14 | 150 | 7 | 15254193 | |
| Pubmed | Translational regulation by HIV leader RNA, TAT, and interferon-inducible enzymes. | 1.16e-12 | 19 | 150 | 7 | 1708818 | |
| Pubmed | 1.16e-12 | 19 | 150 | 7 | 1385305 | ||
| Pubmed | 2.64e-12 | 11 | 150 | 6 | 18835032 | ||
| Pubmed | High-affinity binding of 125I-labelled mouse interferon to a specific cell surface receptor. | 2.64e-12 | 11 | 150 | 6 | 6444699 | |
| Pubmed | Structural and functional neuropathology in transgenic mice with CNS expression of IFN-alpha. | 2.64e-12 | 11 | 150 | 6 | 10448195 | |
| Pubmed | IFN-alpha can both protect against and promote the development of type 1 diabetes. | 2.64e-12 | 11 | 150 | 6 | 19120292 | |
| Pubmed | Effect of interferon-alpha on immediate early gene expression of murine cytomegalovirus. | 2.64e-12 | 11 | 150 | 6 | 8389790 | |
| Pubmed | The mouse IFN-alpha (Ifa) locus: correlation of physical and linkage maps by in situ hybridization. | 2.64e-12 | 11 | 150 | 6 | 3456887 | |
| Pubmed | Mechanism of SUMOylation-Mediated Regulation of Type I IFN Expression. | 2.64e-12 | 11 | 150 | 6 | 36681180 | |
| Pubmed | Type I interferon dependence of plasmacytoid dendritic cell activation and migration. | 2.64e-12 | 11 | 150 | 6 | 15795237 | |
| Pubmed | 2.64e-12 | 11 | 150 | 6 | 9794439 | ||
| Pubmed | 2.64e-12 | 11 | 150 | 6 | 25310498 | ||
| Pubmed | 3.89e-12 | 22 | 150 | 7 | 7913356 | ||
| Pubmed | 5.26e-12 | 12 | 150 | 6 | 16565497 | ||
| Pubmed | Regulation of effector and memory T-cell functions by type I interferon. | 5.26e-12 | 12 | 150 | 6 | 21320124 | |
| Pubmed | MAVS Deficiency Is Associated With a Reduced T Cell Response Upon Secondary RSV Infection in Mice. | 5.26e-12 | 12 | 150 | 6 | 33123150 | |
| Pubmed | A novel anti-viral role for STAT3 in IFN-α signalling responses. | 5.26e-12 | 12 | 150 | 6 | 27988795 | |
| Pubmed | Evolution of the interferon alpha gene family in eutherian mammals. | 5.26e-12 | 12 | 150 | 6 | 17512142 | |
| Pubmed | 5.26e-12 | 12 | 150 | 6 | 8656058 | ||
| Pubmed | Repression of the murine interferon alpha 11 gene: identification of negatively acting sequences. | 5.26e-12 | 12 | 150 | 6 | 1886773 | |
| Pubmed | The physical separation of Lps and Ifa loci in BXH recombinant inbred mice. | 5.26e-12 | 12 | 150 | 6 | 2572648 | |
| Pubmed | Developmental control of IFN-alpha expression in murine embryos. | 5.26e-12 | 12 | 150 | 6 | 7925651 | |
| Pubmed | The role of type 1 interferons in coagulation induced by gram-negative bacteria. | 5.26e-12 | 12 | 150 | 6 | 32016282 | |
| Pubmed | Multiple pathways of interferon-induced gene expression in murine macrophages. | 5.26e-12 | 12 | 150 | 6 | 7684767 | |
| Pubmed | 5.26e-12 | 12 | 150 | 6 | 6188104 | ||
| Pubmed | Ligation of CD180 inhibits IFN-α signaling in a Lyn-PI3K-BTK-dependent manner in B cells. | 5.26e-12 | 12 | 150 | 6 | 26277892 | |
| Pubmed | 5.26e-12 | 12 | 150 | 6 | 6689487 | ||
| Pubmed | Interferon-alpha initiates type 1 diabetes in nonobese diabetic mice. | 5.26e-12 | 12 | 150 | 6 | 18716002 | |
| Pubmed | Negative regulation of the alpha interferon-induced antiviral response by the Ras/Raf/MEK pathway. | 5.26e-12 | 12 | 150 | 6 | 16611902 | |
| Pubmed | 5.26e-12 | 12 | 150 | 6 | 30967261 | ||
| Pubmed | Interferon-alpha subtype 11 activates NK cells and enables control of retroviral infection. | 5.26e-12 | 12 | 150 | 6 | 22912583 | |
| Pubmed | 5.26e-12 | 12 | 150 | 6 | 23747509 | ||
| Pubmed | 5.26e-12 | 12 | 150 | 6 | 17434974 | ||
| Pubmed | 5.26e-12 | 12 | 150 | 6 | 18937499 | ||
| Pubmed | Structure and expression of a new murine interferon-alpha gene: MuIFN-alpha I9. | 5.26e-12 | 12 | 150 | 6 | 3758677 | |
| Pubmed | 5.26e-12 | 12 | 150 | 6 | 19406830 | ||
| Pubmed | 5.26e-12 | 12 | 150 | 6 | 8245849 | ||
| Pubmed | 5.26e-12 | 12 | 150 | 6 | 22685550 | ||
| Pubmed | 5.26e-12 | 12 | 150 | 6 | 3017340 | ||
| Pubmed | 5.26e-12 | 12 | 150 | 6 | 20038206 | ||
| Pubmed | Murine alpha/beta interferons inhibit benzo(a)pyrene activation and mutagenesis in mice. | 5.26e-12 | 12 | 150 | 6 | 8304945 | |
| Pubmed | 5.26e-12 | 12 | 150 | 6 | 11846978 | ||
| Pubmed | Identification of distal silencing elements in the murine interferon-A11 gene promoter. | 5.26e-12 | 12 | 150 | 6 | 8760352 | |
| Pubmed | Behavioral effects of mouse interferons-alpha and -gamma and human interferon-alpha in mice. | 5.26e-12 | 12 | 150 | 6 | 1422836 | |
| Pubmed | Role of interferons in the regulation of cell proliferation, differentiation, and development. | 5.26e-12 | 12 | 150 | 6 | 7530016 | |
| Pubmed | 5.26e-12 | 12 | 150 | 6 | 17277125 | ||
| Pubmed | 5.26e-12 | 12 | 150 | 6 | 9794206 | ||
| Pubmed | Isolation and mapping of four new DNA markers from mouse chromosome 4. | 5.26e-12 | 12 | 150 | 6 | 1360280 | |
| Pubmed | 5.26e-12 | 12 | 150 | 6 | 17451966 | ||
| Pubmed | 5.26e-12 | 12 | 150 | 6 | 25897172 | ||
| Pubmed | A polymorphic trinucleotide repeat sequence mapping to distal mouse chromosome 4. | 5.26e-12 | 12 | 150 | 6 | 8672140 | |
| Pubmed | 5.26e-12 | 12 | 150 | 6 | 7601556 | ||
| Pubmed | Characterization of interferon-alpha 13, a novel constitutive murine interferon-alpha subtype. | 9.74e-12 | 13 | 150 | 6 | 12930842 | |
| Pubmed | Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. | 9.74e-12 | 13 | 150 | 6 | 2014240 | |
| Pubmed | 9.74e-12 | 13 | 150 | 6 | 18005734 | ||
| Pubmed | 9.74e-12 | 13 | 150 | 6 | 12050368 | ||
| Pubmed | Isolation and bacterial expression of a murine alpha leukocyte interferon gene. | 9.74e-12 | 13 | 150 | 6 | 6094686 | |
| Pubmed | 9.74e-12 | 13 | 150 | 6 | 2993652 | ||
| Pubmed | 9.74e-12 | 13 | 150 | 6 | 1655578 | ||
| Pubmed | 9.74e-12 | 13 | 150 | 6 | 2471809 | ||
| Pubmed | 9.74e-12 | 13 | 150 | 6 | 21263073 | ||
| Pubmed | 9.74e-12 | 13 | 150 | 6 | 8438572 | ||
| Pubmed | 9.74e-12 | 13 | 150 | 6 | 38660315 | ||
| Pubmed | 9.74e-12 | 13 | 150 | 6 | 9343822 | ||
| Pubmed | Evidence for a different susceptibility of primate lentiviruses to type I interferons. | 9.74e-12 | 13 | 150 | 6 | 23255800 | |
| Pubmed | 9.74e-12 | 13 | 150 | 6 | 7523540 | ||
| Pubmed | 9.74e-12 | 13 | 150 | 6 | 19635904 | ||
| Pubmed | 9.74e-12 | 13 | 150 | 6 | 19706714 | ||
| Pubmed | 9.74e-12 | 13 | 150 | 6 | 23804712 | ||
| Pubmed | 9.74e-12 | 13 | 150 | 6 | 22431588 | ||
| Pubmed | Mouse interferon alpha and beta genes are linked at the centromere proximal region of chromosome 4. | 9.74e-12 | 13 | 150 | 6 | 3973562 | |
| Pubmed | Organization, structure and expression of murine interferon alpha genes. | 9.74e-12 | 13 | 150 | 6 | 2987810 | |
| Pubmed | 9.74e-12 | 13 | 150 | 6 | 19130550 | ||
| Pubmed | 9.74e-12 | 13 | 150 | 6 | 21469099 | ||
| Pubmed | 9.74e-12 | 13 | 150 | 6 | 22739040 | ||
| Pubmed | 9.74e-12 | 13 | 150 | 6 | 20065291 | ||
| Pubmed | Effects of IFN alpha on late stages of HIV-1 replication cycle. | 9.74e-12 | 13 | 150 | 6 | 9865497 | |
| Pubmed | 9.74e-12 | 13 | 150 | 6 | 9181467 | ||
| Pubmed | 9.74e-12 | 13 | 150 | 6 | 17723216 | ||
| Pubmed | 9.74e-12 | 13 | 150 | 6 | 20427526 | ||
| Pubmed | Sequencing and bacterial expression of a novel murine alpha interferon gene. | 9.74e-12 | 13 | 150 | 6 | 18726328 | |
| Pubmed | 9.74e-12 | 13 | 150 | 6 | 18572754 | ||
| Pubmed | 9.74e-12 | 13 | 150 | 6 | 15723075 | ||
| Pubmed | 1.70e-11 | 14 | 150 | 6 | 22815848 | ||
| Pubmed | Dual regulatory roles of phosphatidylinositol 3-kinase in IFN signaling. | 1.70e-11 | 14 | 150 | 6 | 18981154 | |
| Pubmed | 1.70e-11 | 14 | 150 | 6 | 19620305 | ||
| Pubmed | Interferon induction by HIV glycoprotein 120: role of the V3 loop. | 1.70e-11 | 14 | 150 | 6 | 7526537 | |
| Pubmed | 1.70e-11 | 14 | 150 | 6 | 19559726 | ||
| Pubmed | 1.70e-11 | 14 | 150 | 6 | 15240719 | ||
| Pubmed | 1.70e-11 | 14 | 150 | 6 | 16418394 | ||
| Pubmed | 1.70e-11 | 14 | 150 | 6 | 18272764 | ||
| Pubmed | 1.70e-11 | 14 | 150 | 6 | 11884139 | ||
| Pubmed | 1.70e-11 | 14 | 150 | 6 | 19004943 | ||
| Pubmed | Differential constitutive expression of interferon genes in early mouse embryos. | 1.70e-11 | 14 | 150 | 6 | 7654369 | |
| Pubmed | 1.70e-11 | 14 | 150 | 6 | 2552026 | ||
| Pubmed | Modulation of interferon-mediated inhibition of human immunodeficiency virus type 1 by Tat. | 1.70e-11 | 14 | 150 | 6 | 7532202 | |
| Pubmed | 1.70e-11 | 14 | 150 | 6 | 18200012 | ||
| Pubmed | Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. | 1.70e-11 | 14 | 150 | 6 | 18200009 | |
| Pubmed | Type I IFN enhances follicular B cell contribution to the T cell-independent antibody response. | 1.70e-11 | 14 | 150 | 6 | 20566717 | |
| Interaction | IFNA13 interactions | 8.39e-07 | 11 | 146 | 4 | int:IFNA13 | |
| Interaction | RNF123 interactions | MRM2 PPP1R3E TTI2 UBR4 BCL3 PGAM5 DSCAML1 LRRC47 FANCA TMCO4 RNF123 RANBP3L ZFR2 EXOC3L4 CHRD CEP295 DYNC1H1 ELP4 MOV10 | 8.18e-06 | 824 | 146 | 19 | int:RNF123 |
| Interaction | IFNA5 interactions | 1.75e-05 | 22 | 146 | 4 | int:IFNA5 | |
| Cytoband | 9p22 | 1.58e-12 | 25 | 150 | 7 | 9p22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9p21 | 8.60e-09 | 124 | 150 | 8 | chr9p21 | |
| GeneFamily | Interferons | 5.44e-10 | 32 | 105 | 7 | 598 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.46e-04 | 18 | 105 | 3 | 91 | |
| GeneFamily | Blood group antigens|CD molecules|Proteoglycans | 6.88e-04 | 7 | 105 | 2 | 570 | |
| GeneFamily | Shisa family members | 9.14e-04 | 8 | 105 | 2 | 742 | |
| GeneFamily | Adenylate kinases | 1.17e-03 | 9 | 105 | 2 | 356 | |
| GeneFamily | Adenylate cyclases|Deafness associated genes | 1.46e-03 | 10 | 105 | 2 | 53 | |
| GeneFamily | UPF1 like RNA helicases | 1.78e-03 | 11 | 105 | 2 | 1169 | |
| GeneFamily | Ankyrin repeat domain containing | 2.89e-03 | 242 | 105 | 6 | 403 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 4.29e-03 | 17 | 105 | 2 | 684 | |
| Coexpression | SHIN_B_CELL_LYMPHOMA_CLUSTER_5 | 2.23e-10 | 29 | 148 | 7 | MM586 | |
| Coexpression | ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_NAIVE_NOT_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP | 2.10e-09 | 39 | 148 | 7 | M41095 | |
| Coexpression | LEE_AGING_NEOCORTEX_DN | 3.57e-07 | 80 | 148 | 7 | MM646 | |
| Coexpression | ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_RESPONDERS_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP | 1.31e-06 | 34 | 148 | 5 | M41094 | |
| Coexpression | WORSCHECH_TUMOR_REJECTION_UP | 6.24e-06 | 80 | 148 | 6 | MM1229 | |
| Coexpression | LEE_CALORIE_RESTRICTION_NEOCORTEX_DN | 8.87e-06 | 85 | 148 | 6 | MM684 | |
| Coexpression | GROSS_HYPOXIA_VIA_HIF1A_DN | 9.87e-06 | 131 | 148 | 7 | MM1127 | |
| Coexpression | LEE_CALORIE_RESTRICTION_NEOCORTEX_UP | 1.01e-05 | 87 | 148 | 6 | MM652 | |
| Coexpression | LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_DT_ANTIBODY_CORRELATION_PROFILE_3DY_UP | 1.55e-05 | 27 | 148 | 4 | M40935 | |
| Coexpression | GSE19198_1H_VS_24H_IL21_TREATED_TCELL_DN | 1.89e-05 | 200 | 148 | 8 | M7230 | |
| Coexpression | LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_POLYSACCHARIDE_ANTIBODY_CORRELATION_PROFILE_3DY_UP | 3.10e-05 | 32 | 148 | 4 | M40934 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | FLII STK36 ATP13A1 PPP1R3E UBR4 BCL3 ZMIZ1 SIK3 PARP10 MYOF ELMO2 MAP4K1 DENND6B FES SMARCD1 PNMA3 | 5.55e-05 | 905 | 148 | 16 | M40865 |
| Coexpression | LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_POLYSACCHARIDE_ANTIBODY_CORRELATION_PROFILE_3DY_DN | 9.36e-05 | 16 | 148 | 3 | M40964 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 3.72e-07 | 199 | 149 | 8 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.63e-06 | 190 | 149 | 7 | f50b9814a1beac67dc042a8c27dfd085ceeda3a6 | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.63e-06 | 190 | 149 | 7 | a22a510b4a257eb0eaf09c7ae7978d3d2f07a58c | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.63e-06 | 190 | 149 | 7 | 57c136bf6d7feafb4a220877bed0cc8fdf314db2 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-06 | 196 | 149 | 7 | 90edf61116ffcb4f8b6be3d0a05732d59b0a87d5 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-06 | 196 | 149 | 7 | c936014125b2ed5f796221b74acb77b8f8359875 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_A2|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.78e-06 | 133 | 149 | 6 | 8ff1cf0ea1fc33fe8384c0e65c1ee1853b25a2ae | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Nxph3-Excitatory_Neuron.Slc17a7.Nxph3-Hpcal1-Fos_(Entorhinal_cortex_(IEG))|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.61e-05 | 94 | 149 | 5 | a4d0eefede392b55d17ae9995237a2278a570e42 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Nxph3-Excitatory_Neuron.Slc17a7.Nxph3-Hpcal1-Fos_(Entorhinal_cortex_(IEG))-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.61e-05 | 94 | 149 | 5 | 517e9762e5362b6ff48f0918468a70b736f4d0de | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-05 | 173 | 149 | 6 | 8fb32a9f2dbec16de840d55b4db7e7718f5a2a7a | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-05 | 173 | 149 | 6 | f663571aaae2365660a8b526c355f4bd1a124a74 | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.67e-05 | 174 | 149 | 6 | 6688424fc4e40c3c4a89669a2bc79369a726f1e6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.75e-05 | 175 | 149 | 6 | e5467dacf81f1f913b1719931cf1a7331434a7e7 | |
| ToppCell | metastatic_Brain-T/NK_cells-Exhausted_Tfh|metastatic_Brain / Location, Cell class and cell subclass | 2.75e-05 | 175 | 149 | 6 | b732c6a423c28856211002107d8c611dcfb6f265 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Myeloid-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-05 | 178 | 149 | 6 | ee674e379ee57e40eb2560ff5ed4c13d8db7ed9d | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Myeloid|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-05 | 178 | 149 | 6 | 6c45bf197d6c1be0ef7d3a644c0062acf1e24e4d | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Myeloid-macrophage|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-05 | 178 | 149 | 6 | cd85dcefe94ee742db64b63e105e13532321894a | |
| ToppCell | 5'-Adult-Appendix-Epithelial-Tuft-related-Microfold_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.13e-05 | 179 | 149 | 6 | 7aa4137f672dadb3be92009cde6e0ea60a15372d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.22e-05 | 180 | 149 | 6 | 9e09b3dfe344b5d50520711513d389865d73a861 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.76e-05 | 185 | 149 | 6 | 03f64a7132b13a01ba47187e0e15c13ac88f7cb2 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-05 | 187 | 149 | 6 | 59313a47a6012b2413d7d3673bb05fb7e49fd88f | |
| ToppCell | P15-Epithelial-airway_epithelial_cell-club_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.99e-05 | 187 | 149 | 6 | a70aaae32426e9ddb1cbfbd0e0db24ccc96b9f40 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-05 | 187 | 149 | 6 | 2591fe1552cd10925ad1d8d1f062a057ce6bdad9 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 4.11e-05 | 188 | 149 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | P15-Epithelial-airway_epithelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.11e-05 | 188 | 149 | 6 | e3e71c0f2e374330620cb4d27638953ffa9f5298 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD|kidney_cells / Celltypes from Cells and Nuclei per compartment and clinical group | 4.11e-05 | 188 | 149 | 6 | 90188b60ff893754f7938fe8edab79758827168e | |
| ToppCell | Control-B_intermediate-6|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.23e-05 | 189 | 149 | 6 | 11cb9a16f1de8f60af2073ed7ea6d4f41c02f299 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.49e-05 | 191 | 149 | 6 | 9c5d88f0d3c834c2419ec3da74652175153ba9df | |
| ToppCell | Calu_3-infected-SARSCoV2|infected / Cell line, Condition and Strain | 4.49e-05 | 191 | 149 | 6 | 2da876d26f37a00dbdf1ee79d724306e8b20f304 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.49e-05 | 191 | 149 | 6 | a7494191a92984e5f53610bbbedd6714e9169e1c | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 4.62e-05 | 192 | 149 | 6 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | moderate-Myeloid-Monocyte-derived_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.76e-05 | 193 | 149 | 6 | 22455801194bd8c73c5c397f5eac4f723429c383 | |
| ToppCell | Mild|World / Disease group and Cell class | 5.18e-05 | 196 | 149 | 6 | 5e4ed4a5a437cfa002b92775992a791e27aa4c27 | |
| ToppCell | Mild-CD8+_T_activated|World / Disease group and Cell class | 5.18e-05 | 196 | 149 | 6 | 79632190e44fcef9d7c11d9b9e37f2ebf0e6e255 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_immature-endo_immature_venous_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.33e-05 | 197 | 149 | 6 | 88859b7b24b36afab4a684fd7abf0e0f8e5b525c | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.48e-05 | 198 | 149 | 6 | d5e125f0c4f41b47d567568d0838adcca7655f6d | |
| ToppCell | mLN-Dendritic_cell-cDC2|mLN / Region, Cell class and subclass | 5.64e-05 | 199 | 149 | 6 | cb17bccb47d04f7793709f9a4376fcc8ce95430c | |
| ToppCell | mLN-(5)_Dendritic_cell-(50)_cDC2|mLN / shred on region, Cell_type, and subtype | 5.64e-05 | 199 | 149 | 6 | 8d1b18596a0965427abefe0be744c74e4c11d5d3 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.80e-05 | 200 | 149 | 6 | a3a1e35934d676c39f917652e50c502cb2f613c1 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.88e-05 | 123 | 149 | 5 | 87401764a073c1808f214642a9c84299c78f7ec7 | |
| ToppCell | LPS_only-Lymphocytic_NKT-T_cells-iNKT-MAIT|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.11e-05 | 124 | 149 | 5 | 05e114fcfe84cfc8d92978a4eda6db4d8a616e0e | |
| ToppCell | (50)_cDC2|World / shred on Cell_type and subtype | 6.83e-05 | 206 | 149 | 6 | d519adeb8290fcce107e81a439ba3bf1e231b55b | |
| Computational | Neighborhood of ERCC4 | 2.16e-05 | 30 | 60 | 4 | GCM_ERCC4 | |
| Computational | Neighborhood of PTPRD | 2.97e-04 | 58 | 60 | 4 | GCM_PTPRD | |
| Computational | Genes in the cancer module 372. | 3.08e-04 | 24 | 60 | 3 | MODULE_372 | |
| Computational | Neighborhood of MAP4K4 | 3.77e-04 | 172 | 60 | 6 | GCM_MAP4K4 | |
| Drug | 1 ind | 2.83e-07 | 42 | 147 | 6 | CID003037877 | |
| Drug | sorafenib | 9.03e-07 | 158 | 147 | 9 | CID000216239 | |
| Drug | R 842 | 1.14e-06 | 13 | 147 | 4 | CID000130714 | |
| Drug | poly rI:rC | 1.31e-06 | 30 | 147 | 5 | CID011979660 | |
| Drug | gunacin | 1.59e-06 | 14 | 147 | 4 | CID000198547 | |
| Drug | pppA2'-5'A2'-5'A | 2.15e-06 | 15 | 147 | 4 | CID000125229 | |
| Drug | imiquimod | 2.34e-06 | 132 | 147 | 8 | CID000057469 | |
| Drug | anagrelide | 4.43e-06 | 38 | 147 | 5 | CID000002182 | |
| Drug | podophyllin | 4.76e-06 | 18 | 147 | 4 | CID011979494 | |
| Drug | Nyco | 4.76e-06 | 18 | 147 | 4 | CID000071618 | |
| Drug | isofagomine lactam | 5.06e-06 | 39 | 147 | 5 | CID000448980 | |
| Drug | benzoylacetate | 5.20e-06 | 6 | 147 | 3 | CID000097045 | |
| Drug | Sesquimustard | 8.28e-06 | 43 | 147 | 5 | CID000019092 | |
| Drug | oligoadenylate | 8.47e-06 | 157 | 147 | 8 | CID000107918 | |
| Drug | Yfrkd | 9.06e-06 | 7 | 147 | 3 | CID000129984 | |
| Drug | dideoxyinosine | 9.12e-06 | 75 | 147 | 6 | CID000003043 | |
| Drug | NSC-218321 | 9.37e-06 | 114 | 147 | 7 | CID000004739 | |
| Drug | butyrate | ABHD6 OAS2 PODXL2 ITGAM ADCY5 ITGB7 ADCY6 IFNA4 SLC2A4 IFNA10 IFNA17 IFNW1 TKFC TONSL C2 CTNNB1 GPR148 | 9.78e-06 | 767 | 147 | 17 | CID000000264 |
| Drug | dipyridamole | 1.07e-05 | 162 | 147 | 8 | CID000003108 | |
| Drug | formosanin C | 1.11e-05 | 22 | 147 | 4 | CID000073597 | |
| Drug | Hiltonol | 1.34e-05 | 23 | 147 | 4 | CID000431963 | |
| Drug | 1hiv | 1.44e-05 | 8 | 147 | 3 | CID005479205 | |
| Drug | Chebi:36708 | 1.44e-05 | 8 | 147 | 3 | CID011966289 | |
| Drug | Azitidin | 1.45e-05 | 169 | 147 | 8 | CID000005726 | |
| Drug | cycloferon | 1.60e-05 | 24 | 147 | 4 | CID000038072 | |
| Drug | temozolomide | 1.90e-05 | 127 | 147 | 7 | CID000005394 | |
| Drug | hycanthone | 1.90e-05 | 25 | 147 | 4 | CID000003634 | |
| Drug | LB80380 | 1.90e-05 | 25 | 147 | 4 | CID006480442 | |
| Drug | ABMP | 2.23e-05 | 26 | 147 | 4 | CID000080567 | |
| Drug | Ampligen | 2.34e-05 | 53 | 147 | 5 | CID000038077 | |
| Drug | AC1L40MO | 2.56e-05 | 133 | 147 | 7 | CID000099067 | |
| Drug | inosiplex | 2.61e-05 | 27 | 147 | 4 | CID000037510 | |
| Drug | pipobroman | 3.06e-05 | 10 | 147 | 3 | CID000004842 | |
| Drug | m IU | 3.07e-05 | 56 | 147 | 5 | CID006852123 | |
| Drug | Beryllium | 3.07e-05 | 56 | 147 | 5 | CID000107649 | |
| Drug | halothane | PRKD2 ADCY5 ADCY6 IFNA4 IFNA10 IFNA17 IFNW1 CACNG7 C2 CACNG5 | 3.87e-05 | 314 | 147 | 10 | CID000003562 |
| Drug | DDPO | 4.14e-05 | 2 | 147 | 2 | CID003081172 | |
| Drug | hexametazine | 4.14e-05 | 2 | 147 | 2 | CID009552070 | |
| Drug | flesinoxan | 4.19e-05 | 11 | 147 | 3 | CID000057347 | |
| Drug | Cyclobenzaprine hydrochloride [6202-23-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 4.20e-05 | 196 | 147 | 8 | 4834_DN | |
| Drug | Allantoin [97-59-6]; Up 200; 25.2uM; MCF7; HT_HG-U133A | 4.67e-05 | 199 | 147 | 8 | 5471_UP | |
| Drug | imidazoquinoline | 5.01e-05 | 101 | 147 | 6 | CID005351568 | |
| Drug | CHEMBL466993 | 5.21e-05 | 32 | 147 | 4 | CID005320808 | |
| Drug | 5H-purin-2-amine | 5.29e-05 | 102 | 147 | 6 | CID000409844 | |
| Drug | Cytosar-U | PRKD2 STK36 ITGAM IFNA4 IFNA10 IFNA17 IFNW1 TONSL RPUSD2 SLC29A1 GPR148 | 5.87e-05 | 399 | 147 | 11 | CID000000596 |
| Drug | tegafur/uracil | 5.90e-05 | 33 | 147 | 4 | CID000104747 | |
| Drug | mitoxantrone | 6.52e-05 | 154 | 147 | 7 | CID000004212 | |
| Drug | carprofen | 6.65e-05 | 34 | 147 | 4 | CID000002581 | |
| Drug | tenofovir disoproxil fumarate | 6.65e-05 | 34 | 147 | 4 | CID005481350 | |
| Drug | copolymer 1 | 6.82e-05 | 66 | 147 | 5 | CID003081884 | |
| Drug | 3-aminobenzamide | 7.07e-05 | 156 | 147 | 7 | CID000001645 | |
| Drug | AC1L1BJN | 7.19e-05 | 13 | 147 | 3 | CID000001467 | |
| Drug | AC1O52EF | 7.19e-05 | 13 | 147 | 3 | CID006450817 | |
| Drug | tilorone | 7.47e-05 | 35 | 147 | 4 | CID000005475 | |
| Drug | MCNU | 8.37e-05 | 36 | 147 | 4 | CID000071741 | |
| Drug | AC1O3GBZ | 8.37e-05 | 36 | 147 | 4 | CID006327751 | |
| Drug | cycloleucine | 8.45e-05 | 69 | 147 | 5 | CID000002901 | |
| Drug | Lanicemine | 9.11e-05 | 14 | 147 | 3 | CID003038485 | |
| Drug | pyran | 9.33e-05 | 37 | 147 | 4 | CID000033703 | |
| Drug | FMAU | 9.33e-05 | 37 | 147 | 4 | CID000072327 | |
| Drug | resiquimod | 1.03e-04 | 115 | 147 | 6 | CID000159603 | |
| Drug | ridostin | 1.08e-04 | 116 | 147 | 6 | CID011979623 | |
| Drug | AC1L9NBB | 1.17e-04 | 169 | 147 | 7 | CID000449615 | |
| Drug | myristamide | 1.24e-04 | 3 | 147 | 2 | CID000069492 | |
| Drug | caldarchaeol | 1.24e-04 | 3 | 147 | 2 | CID005388885 | |
| Drug | xanthine | 1.25e-04 | 119 | 147 | 6 | CID000001188 | |
| Drug | AC1L1GVK | 1.34e-04 | 76 | 147 | 5 | CID000003860 | |
| Drug | 2',3'-dideoxycytidine (ddC | 1.34e-04 | 76 | 147 | 5 | CID000005718 | |
| Drug | acyclovir | 1.56e-04 | 124 | 147 | 6 | CID000002022 | |
| Drug | YNK01 | 1.68e-04 | 17 | 147 | 3 | CID000084071 | |
| Drug | Zinetac | 1.71e-04 | 80 | 147 | 5 | CID000005039 | |
| Drug | DTIC | 1.81e-04 | 81 | 147 | 5 | CID005281007 | |
| Drug | 2-chloro-3'-deoxyadenosine | 1.85e-04 | 44 | 147 | 4 | CID003034808 | |
| Drug | plakin | 1.92e-04 | 82 | 147 | 5 | CID000018752 | |
| Drug | p203 | 2.00e-04 | 18 | 147 | 3 | CID000019228 | |
| Drug | leucovorin | 2.02e-04 | 130 | 147 | 6 | CID000000143 | |
| Drug | m-cresol | 2.03e-04 | 83 | 147 | 5 | CID000000342 | |
| Drug | AC1L9AL3 | 2.20e-04 | 46 | 147 | 4 | CID000441122 | |
| Drug | glycrrhizin | 2.40e-04 | 86 | 147 | 5 | CID000003495 | |
| Drug | entecavir | 2.40e-04 | 47 | 147 | 4 | CID000153941 | |
| Drug | ethoxyacetylene | 2.46e-04 | 4 | 147 | 2 | CID000061239 | |
| Drug | barium iodide | 2.46e-04 | 4 | 147 | 2 | CID000083684 | |
| Drug | NSC759576 | 2.48e-04 | 191 | 147 | 7 | CID000003075 | |
| Disease | Gastrointestinal Stromal Sarcoma | 7.81e-05 | 47 | 142 | 4 | C3179349 | |
| Disease | Gastrointestinal Stromal Tumors | 9.97e-05 | 50 | 142 | 4 | C0238198 | |
| Disease | apolipoprotein A 1 measurement | THSD7A LINGO2 BCL3 ZMIZ1 SIK3 LRRC43 ITGAM ADCY5 PTPRR FES HERC1 MGA CSGALNACT1 | 2.40e-04 | 848 | 142 | 13 | EFO_0004614 |
| Disease | Abnormality of refraction | THSD7A FRMPD2 ABHD6 DSCAML1 ADCY5 PTPRR BARHL2 RPUSD2 TRPM1 CTNNB1 SHISA6 | 4.30e-04 | 673 | 142 | 11 | HP_0000539 |
| Disease | progression free survival, response to carboplatin, methylcobalamin deficiency type cblE, ovarian carcinoma | 8.78e-04 | 39 | 142 | 3 | EFO_0001075, EFO_0004920, GO_0097328, MONDO_0009354 | |
| Disease | serum IgG glycosylation measurement | MON2 STAB2 THSD7A FOXP2 LINGO2 RANBP3L PTPRR MARCHF11 SHISA6 | 1.01e-03 | 523 | 142 | 9 | EFO_0005193 |
| Disease | 2-aminobutyrate measurement | 1.01e-03 | 10 | 142 | 2 | EFO_0020017 | |
| Disease | Major Depressive Disorder | 1.18e-03 | 243 | 142 | 6 | C1269683 | |
| Disease | Vitiligo | 1.46e-03 | 101 | 142 | 4 | EFO_0004208 | |
| Disease | chronic musculoskeletal pain | 1.47e-03 | 12 | 142 | 2 | EFO_0022195 | |
| Disease | hair colour measurement, hair morphology measurement | 1.47e-03 | 12 | 142 | 2 | EFO_0007821, EFO_0007822 | |
| Disease | trauma exposure measurement | 1.50e-03 | 172 | 142 | 5 | EFO_0010703 | |
| Disease | Unipolar Depression | 1.63e-03 | 259 | 142 | 6 | C0041696 | |
| Disease | very low density lipoprotein cholesterol measurement | 1.67e-03 | 260 | 142 | 6 | EFO_0008317 | |
| Disease | hyperglycemia (is_marker_for) | 1.73e-03 | 13 | 142 | 2 | DOID:4195 (is_marker_for) | |
| Disease | Fibrosis | 1.81e-03 | 50 | 142 | 3 | C0016059 | |
| Disease | Cirrhosis | 1.81e-03 | 50 | 142 | 3 | C1623038 | |
| Disease | coffee consumption measurement | 1.92e-03 | 182 | 142 | 5 | EFO_0006781 | |
| Disease | total cholesterol measurement, diastolic blood pressure, triglyceride measurement, systolic blood pressure, hematocrit, ventricular rate measurement, glucose measurement, body mass index, high density lipoprotein cholesterol measurement | 1.92e-03 | 51 | 142 | 3 | EFO_0004340, EFO_0004348, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928 | |
| Disease | skin melanoma (is_implicated_in) | 2.01e-03 | 14 | 142 | 2 | DOID:8923 (is_implicated_in) | |
| Disease | Malformations of Cortical Development | 2.01e-03 | 14 | 142 | 2 | C1955869 | |
| Disease | body weights and measures, parental genotype effect measurement | 2.01e-03 | 14 | 142 | 2 | EFO_0004324, EFO_0005939 | |
| Disease | Cortical Dysplasia | 2.01e-03 | 14 | 142 | 2 | C0431380 | |
| Disease | Colorectal Carcinoma | FPGS FRMPD2 ZMIZ1 DSCAML1 ARHGEF10L LRRC47 BPIFB2 CTNNB1 DMD SLC29A1 | 2.18e-03 | 702 | 142 | 10 | C0009402 |
| Disease | Hypermetropia, Myopia | 2.26e-03 | 189 | 142 | 5 | HP_0000540, HP_0000545 | |
| Disease | interleukin 18 receptor 1 measurement | 2.32e-03 | 15 | 142 | 2 | EFO_0008178 | |
| Disease | refractive error, age at onset, Myopia | 2.47e-03 | 193 | 142 | 5 | EFO_0004847, HP_0000545, MONDO_0004892 | |
| Disease | alcohol consumption measurement | THSD7A ANKS1B NPAS3 ZSWIM2 LINGO2 MED1 UBASH3A AK8 CACNG7 LINGO1 BPIFB2 BCAR3 MGA PLXNA2 | 2.73e-03 | 1242 | 142 | 14 | EFO_0007878 |
| Disease | proprotein convertase subtilisin/kexin type 7 measurement | 2.98e-03 | 17 | 142 | 2 | EFO_0008270 | |
| Disease | esophageal carcinoma, gastric carcinoma | 2.98e-03 | 17 | 142 | 2 | EFO_0000178, EFO_0002916 | |
| Disease | hair colour measurement | 3.02e-03 | 615 | 142 | 9 | EFO_0007822 | |
| Disease | Liver carcinoma | 3.25e-03 | 507 | 142 | 8 | C2239176 | |
| Disease | intraocular pressure measurement | 3.33e-03 | 509 | 142 | 8 | EFO_0004695 | |
| Disease | Feeding difficulties | 3.35e-03 | 18 | 142 | 2 | C0232466 | |
| Disease | retinal vasculature measurement | 3.65e-03 | 517 | 142 | 8 | EFO_0010554 | |
| Disease | skin sensitivity to sun | 3.73e-03 | 19 | 142 | 2 | EFO_0004795 | |
| Disease | acetone measurement | 3.73e-03 | 19 | 142 | 2 | EFO_0010989 | |
| Disease | hydrocephalus (implicated_via_orthology) | 3.73e-03 | 19 | 142 | 2 | DOID:10908 (implicated_via_orthology) | |
| Disease | susceptibility to vaginal yeast infection measurement | 3.83e-03 | 65 | 142 | 3 | EFO_0008412 | |
| Disease | Global developmental delay | 3.97e-03 | 133 | 142 | 4 | C0557874 | |
| Disease | urinary microalbumin measurement | 4.13e-03 | 20 | 142 | 2 | EFO_0010967 | |
| Disease | total lipids in small VLDL | 4.17e-03 | 67 | 142 | 3 | EFO_0022148 | |
| Disease | Microcephaly | 4.17e-03 | 67 | 142 | 3 | C0025958 | |
| Disease | Cardiomyopathies, Primary | 4.53e-03 | 69 | 142 | 3 | C0033141 | |
| Disease | Myocardial Diseases, Secondary | 4.53e-03 | 69 | 142 | 3 | C0036529 | |
| Disease | total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer | 4.53e-03 | 69 | 142 | 3 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992 | |
| Disease | Profound Mental Retardation | 4.64e-03 | 139 | 142 | 4 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 4.64e-03 | 139 | 142 | 4 | C0025363 | |
| Disease | Mental deficiency | 4.64e-03 | 139 | 142 | 4 | C0917816 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QQILQGLVDVRIPHN | 226 | Q9BV23 | |
| GHLQRVARPRAQETL | 556 | Q17RC7 | |
| PGQCRHTILLQQRDL | 236 | P60509 | |
| GIPLLGILVQSRHLR | 1041 | Q9HCE0 | |
| SPQQVVRRHILGSIV | 311 | Q9HCE6 | |
| PAIQIHRSTGLRLAQ | 661 | Q6UVK1 | |
| NLIVVRTPVRGLFHL | 461 | Q8TDX6 | |
| HGRIPRQVSENLVQR | 156 | O75815 | |
| RQQERLLLSVLPQHV | 336 | O43306 | |
| QLLRLIPHVQVFARV | 826 | Q9HD20 | |
| LQRLHLVALVGTQGR | 91 | Q08345 | |
| IVHIGQLNRQSILIG | 131 | Q8N7M0 | |
| QRRLGLLLHDSIQIP | 3231 | P11532 | |
| QQQERLLLSVLPRHV | 426 | O95622 | |
| QEQLRLRIGIHTGPV | 966 | P16066 | |
| IQAGLLGRPINHTVR | 501 | Q7L5Y6 | |
| LREKLVRAQGHQLPV | 541 | Q8NEG7 | |
| HRISQPIRQIIYGLL | 366 | Q2TB18 | |
| QALNVRLHLPLPRGV | 326 | O00189 | |
| RQQRTQAHLLVLPKG | 51 | Q5JTZ5 | |
| SRHQIVGSRLRIPQV | 2576 | P98160 | |
| GILNSGHRQRILQAI | 856 | Q7Z6G8 | |
| GHRQRILQAIQLLPK | 861 | Q7Z6G8 | |
| ESQLHLAVRRGNLPL | 1156 | Q8N7Z5 | |
| EIPARLRTLHNLVIQ | 206 | Q9NSK0 | |
| RQHRGPQLLALVEEV | 406 | Q9NZ53 | |
| GAIPRLVQLLVRAHQ | 531 | P35222 | |
| LPQTHSLGNRRALIL | 26 | P01566 | |
| IPRNIGELRNLVSLH | 666 | A4D1F6 | |
| RRLVHLQTLVLNGNP | 171 | Q13045 | |
| NFSINLVPRGIRHLV | 361 | Q4G0Z9 | |
| GQIVQLLPLHQLRGS | 1806 | Q8IWI9 | |
| SLHLRVLGRQLILPT | 316 | A5PLN7 | |
| QIVRVLRTPGNNLHE | 26 | Q8N9N8 | |
| LQLLGSRTHRQPLII | 276 | P14672 | |
| NHLQEIPIIALRNRL | 4336 | O95714 | |
| IHALPGLISQTIRQQ | 521 | Q9H2S1 | |
| LLDRVQHLGAPVTLR | 141 | Q96FN5 | |
| AQGLPQLHSLVLRRN | 71 | Q8N1G4 | |
| HRKLLAVQPSRGLIQ | 921 | Q6ZU64 | |
| LGRKIQIQRSGHLNL | 241 | P06681 | |
| HRLRNLPTINRLEVG | 331 | O00182 | |
| PLVGNLRTRLLALHV | 1946 | Q15751 | |
| LPQTHSLGNRRALIL | 26 | P01568 | |
| NRHLTVLRVVQLQPL | 676 | Q9NRD8 | |
| EQALRIQTLGITPRH | 146 | Q96MA6 | |
| LNIQGAIHRVPALRF | 741 | O75051 | |
| HLVIRPNGRVALRTL | 261 | Q96HS1 | |
| QHLLSLQRQGLISIP | 231 | O15409 | |
| RNEVAILQSLRHPGI | 596 | Q9BZL6 | |
| EAVLQQLHQLPRGRL | 21 | Q96CN5 | |
| LIRLQELHIVGAQLR | 296 | Q7L985 | |
| GLIVLRLRHLNINAI | 216 | Q96FE5 | |
| AVLRGHAPLVRLLLQ | 81 | E5RJM6 | |
| LVRAQALLQRHPGLD | 46 | Q9UBC1 | |
| LLRVLSIGLPVARQH | 1466 | Q7Z3U7 | |
| IRNILLHQLQSARPV | 276 | P29728 | |
| VRQLGHALLVRLQEV | 171 | P26010 | |
| AAALGLLPQQVHINR | 141 | Q15256 | |
| PQGHQVSRLVISIRL | 656 | Q5K4E3 | |
| VSRLVISIRLPQHLG | 661 | Q5K4E3 | |
| ILNNIGHIRPHRTIL | 116 | Q9UF02 | |
| LPQNHGLLSRNTLVL | 26 | P05000 | |
| IILNHVIRGNRPIKT | 266 | Q96JJ3 | |
| HVVSLTNNLIGRRVP | 496 | P57773 | |
| QGPRLHIDIPRVQLL | 1651 | Q8TD84 | |
| AGVQSLVPRLRHQLS | 911 | Q68DX3 | |
| VLTRLCQLLRHQGPS | 761 | O15360 | |
| LVTILRNQRLRQEPH | 71 | Q8TDV2 | |
| VISNIGHIRPQRTIL | 116 | P62955 | |
| QLQRPLVPRVLIHGL | 351 | Q9NY43 | |
| LPLTALRNRNLVHPT | 346 | A6NNE9 | |
| RIDRIFRQPQGHLLL | 2921 | Q14204 | |
| TPIGQAIHRLLLIQA | 3981 | Q14204 | |
| PHLVQVRERIRINGQ | 131 | Q05932 | |
| TFGRHLVRNIQLEQP | 241 | Q96MM7 | |
| LPQTHSLGNRRALIL | 26 | P32881 | |
| LRPGVSILALHGRQQ | 336 | Q13206 | |
| GLIHIRQIPRLNNLI | 346 | Q96EB1 | |
| INVHRPVQKLIRLCG | 126 | Q5W0V3 | |
| LRQHPLRFILQLVVS | 141 | Q15125 | |
| IAVVQGNLPAVHRLV | 141 | P20749 | |
| SHLQIPQLQDRLLRI | 1326 | Q9C0D2 | |
| LPQTHSLGNRRALIL | 26 | P01571 | |
| PGRVPLILNLIRHQV | 401 | Q15648 | |
| TLRHLRLLVLQGNPL | 246 | Q8N309 | |
| LQLALHRSLEPQGQV | 656 | Q53GL7 | |
| TGNLLIILAIRFNPH | 41 | Q8NGR8 | |
| HPRERVQLLGKRQVL | 346 | P07332 | |
| HQLVSQPGLNRGLIL | 271 | Q92918 | |
| QLTALPRHGRIIQQL | 1231 | P0C091 | |
| QIRVHLQFLGHPILN | 371 | Q8IZ73 | |
| LPGHTRLRNQITEVL | 146 | Q9NUJ3 | |
| PIISINGARRNHIVQ | 1291 | Q5TCS8 | |
| VRLLQQGHRCLLAPV | 6 | Q9H9J2 | |
| HILLSRQQGRRPVTL | 386 | Q5TGY1 | |
| LARLLGIHTQTRPVI | 301 | Q96GM5 | |
| QELLRNRPISLGHVV | 136 | Q9BVQ7 | |
| KQSRHRVIIQLPANG | 796 | Q9UPZ6 | |
| RQPLRVQHRALELTG | 451 | Q9HCE1 | |
| LPQTHSLGNRRALIL | 26 | P05015 | |
| NLSVPIGRFQNRVHL | 76 | Q86YT9 | |
| RVPRHVQIQLQRDAL | 111 | Q9H7J1 | |
| HVLNRVPLRQLLRLQ | 31 | Q9H469 | |
| GHIRVQCINPSNLLL | 421 | Q9UL41 | |
| LLGVQTDQRVLRHLI | 241 | Q96HU1 | |
| IPHQAQRIQGIKRLS | 571 | Q6AI14 | |
| NIQLHAQQLLKRPRG | 556 | Q9Y2K2 | |
| IHRALADILRQQGPI | 211 | Q6ZSJ9 | |
| NVPRALVDILRHQAG | 221 | A6NL88 | |
| QQLTRLRHPRLLTVQ | 91 | Q6P3W7 | |
| LQAGNVVLPLVHRVT | 796 | Q8IXF0 | |
| QRQILAVHLLQAVLP | 781 | Q9BVR0 | |
| LPQTHSLGNRRALIL | 26 | P05014 | |
| QGHVLLLRSQPVLRV | 606 | P11215 | |
| FLHQRIPQSVRILGS | 101 | Q99808 | |
| ALRSLQQEPGIHQVL | 1256 | Q9NRP7 | |
| RNGVPLLRRLQTHLQ | 551 | P55201 | |
| GEALQPTRIRILNVH | 61 | Q8N4F0 | |
| QVPLRLQILHQGQLL | 331 | Q9H2X0 | |
| TLVNNVRLPRGHRLE | 81 | Q9Y242 | |
| LIICNVTGIAHRRPQ | 1166 | Q7KZ85 | |
| PRLQGHVVLAQCRVL | 366 | Q96I15 | |
| GILLQALPRLLQHAA | 6 | Q6YI46 | |
| HQIPQRHLRSQLGRL | 96 | Q15935 | |
| HSLLRRIAQQLPRQL | 686 | Q9UPR6 | |
| APQLVLQLSLLVHRG | 241 | Q5GH72 | |
| LRILPVHNTVNAINL | 116 | Q5VVC0 | |
| LPAFVNRLGILTVRH | 366 | Q6NXR4 | |
| APIRTLVQRIHQLQA | 36 | Q96EN9 | |
| RLRGQPTVLLTLAHI | 306 | Q5XPI4 | |
| QLRRVQDLVRQGHPL | 541 | Q96HA7 | |
| HVIRPAILQLPQARS | 121 | Q86VV4 | |
| NRVHLLGRVGQDPVL | 31 | Q04837 | |
| RVRIVQLLLQHGADV | 381 | O95271 | |
| HIINKVLVPQRRLTG | 1121 | Q8WWQ8 | |
| HLSLIVRFPNQGRQV | 886 | O00507 | |
| LEVNERHQILRPGLR | 61 | Q9UI43 | |
| LRNVEGLRHPRINVL | 571 | Q9P2E3 | |
| NTRLGPPNTLHLLVR | 501 | Q7Z4N2 | |
| ISDLLRGIHRVQTPQ | 106 | Q8NEG5 | |
| PLELSRVGNILHRLQ | 1406 | O43379 | |
| VRFQHQVLLVALLGP | 61 | Q9H6L2 | |
| RQNSGRGLVHLILIR | 56 | A0A0B4J275 | |
| ARNLRVDLQRGLIHP | 81 | Q16401 | |
| GQHLVQQLVLRTVRG | 136 | Q9H497 | |
| LAQALVVQLGHRRIA | 211 | Q53SZ7 | |
| PNLQLLQGHRVALRS | 26 | Q3LXA3 | |
| IHRVNAGTLAVLQRL | 516 | A3KMH1 | |
| LRGLAIQHPGTQVLI | 4726 | Q5T4S7 | |
| VRFPIRLEGLVLTHQ | 301 | Q6SJ96 | |
| LVHRPSVRSVLQGLL | 681 | Q9ULJ6 | |
| QRTLEQLARAIPLGH | 246 | P57075 | |
| RSLGIVEQLTRLQHP | 606 | A6NNM8 | |
| RLALHILRTQGLVPE | 1726 | Q9NZM1 |